NP Life Sciences Health Industry Group Inc.
ACAT · Services-Educational Services · 43.0M shares · EDGAR filings ↗
Grade
D52gen composite 41pct→63; net + operating loss
Notable findings
- No interest coverageInterest coverage -1.07 (cannot cover interest)
- Net lossNet loss (net margin -1.8%)
- Revenue declineRevenue -78.3% YoY
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Operating margin
-0.4%
Net margin
-1.8%
Return on equity
-17.9%
Return on assets
-3.8%
ROIC
-3.3%
Revenue growth (QoQ)
-78.3%
Interest coverage
-1.1×
Tangible book value
$16K
Cash & investments
$71K
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 10-K | 2024-04-16 | 2023-12-31 | 0001493152-24-014774 ↗ |
| 10-Q | 2023-11-14 | 2023-09-30 | 0001493152-23-041311 ↗ |
| 10-Q | 2023-08-14 | 2023-06-30 | 0001493152-23-028270 ↗ |
| 10-Q | 2023-05-15 | 2023-03-31 | 0001493152-23-016948 ↗ |
| 10-K | 2023-04-18 | 2022-12-31 | 0001493152-23-012632 ↗ |
| 10-Q | 2022-11-14 | 2022-09-30 | 0001493152-22-032048 ↗ |
| 8-K | 2022-09-08 | 2022-09-02 | 0001493152-22-025370 ↗ |
| 10-Q | 2022-08-15 | 2022-06-30 | 0001493152-22-022753 ↗ |
| 10-Q | 2022-05-23 | 2022-03-31 | 0001493152-22-014774 ↗ |
| 10-K | 2022-04-15 | 2021-12-31 | 0001493152-22-010074 ↗ |
| 8-K | 2021-12-02 | 2021-10-25 | 0001493152-21-030293 ↗ |
| 10-Q | 2021-11-22 | 2021-09-30 | 0001493152-21-029587 ↗ |